PiR36712 inhibits breast cancer metastasis and chemotherapy resistance by regulating the function of SEPW1 (15) and piRNA participate in the metastasis of pancreatic cancer simultaneously (16), and piR54265 promotes the proliferation and migration of colorectal cancer (17). Here, SELENOW is linked to breast carcinoma.